查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495387

醫院感染控制市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2033

Hospital Acquired Infection Control Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 201 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究最近發佈了一份關於全球醫院感染控制市場的綜合報告。該報告全面評估了主要市場動態，包括市場驅動因素、趨勢、機會和課題，並提供了有關市場結構的詳細見解。

關鍵見解

  • 醫院感染控制市場規模（2024 年）：71.3 億美元
  • 預測市場規模（2033 年）：101 億美元
  • 全球市場成長率（複合年增長率，2024-2033 年）：3.9%

醫院感染控制市場 - 報告範圍：

醫院獲得性感染 (HAI) 是患者在醫療機構接受內科或外科手術治療時發生的感染。抗HAI市場包括旨在預防、診斷和治療泌尿道感染、手術部位感染、肺炎和血液感染等傳染病的產品和服務。該市場的主要產品包括滅菌器、消毒劑、監測系統和診斷設備。抗HAI市場涵蓋醫院、診所、長期照護機構和診斷實驗室。

推動市場成長的因素：

全球醫院感染控制市場受到幾個關鍵因素的推動，例如醫院感染的流行、醫療保健支出的增加以及旨在提高患者安全的嚴格法規。滅菌和消毒技術的進步以及創新診斷工具的發展正在提高感染控制措施的有效性。此外，提高醫療保健專業人員和患者對感染預防的認識和教育也正在推動市場成長。

市場限制因素：

儘管成長前景廣闊，但醫院感染控制市場面臨先進感染控制產品和設備的高成本、監管合規性以及醫護人員持續培訓的需求等課題。管理感染控制產品的製造和使用的嚴格法規給製造商和醫療保健提供者帶來了合規負擔，影響了市場進入障礙和營運成本。此外，某些感染控製程序的報銷範圍有限，這給市場滲透帶來了課題，特別是在醫療保健預算有限的新興國家。

市場機會：

技術創新、人口趨勢和不斷發展的醫療保健服務模式為醫院感染治療市場帶來了巨大的成長機會。即時感染監測系統和電子健康記錄等數位健康技術的整合提高了感染控制計劃的有效性。此外，微創外科手術的日益普及和門診護理環境的擴大也為市場參與者開闢了新的途徑。戰略合作夥伴關係、研發投資以及引入具有成本效益且易於使用的感染控制解決方案對於利用新機會和保持市場領先地位至關重要。

本報告解決的關鍵問題

  • 推動全球醫院感染控制市場成長的關鍵因素是什麼？
  • 哪些產品和應用正在推動各種醫療保健環境的採用？
  • 技術進步如何改變 HAI 控制市場的競爭格局？
  • 誰是 HAI Control 市場的主要參與者？
  • 全球HAI控制市場的新趨勢和未來前景是什麼？

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含/排除

第三章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章關鍵成功因素

  • 產品採用/使用分析
  • 主要行銷/促銷策略：依製造商分類
  • 監理狀況
  • 退款場景
  • 品質監控計劃
  • PESTEL 分析
  • 波特的分析

第五章市場背景

  • 宏觀經濟因素
  • 預測因子 - 相關性和影響
  • 市場動態

第 6 章 COVID-19 危機分析

  • 2024 年市場情景
  • 新冠肺炎 (COVID-19) 與影響分析
    • 依產品
    • 依最終用戶
    • 依地區

第七章全球醫院感染控制市場需求分析

  • 過去的市場分析：2019-2023 年
  • 2024-2033 年當前與未來市場預測
    • 年成長趨勢分析

第 8 章全球醫院感染控制市場 - 價格分析

  • 區域價格分析：依產品分類
  • 價格明細
    • 製造商等級定價
    • 經銷商級定價
  • 世界平均價格分析基準
  • 定價假設

第九章全球醫院感染控制市場需求分析

  • 過去的市值分析：2019-2023 年
  • 2024-2033 年當前與未來市場價值預測
    • 年成長趨勢分析
    • 絕對數量機會分析

第 10 章全球醫院感染控制市場分析：依產品

  • 簡介/主要發現
  • 過去的市場規模與銷售分析：依產品分類，2019-2023 年
  • 當前和未來的市場規模和數量分析與預測：依產品分類，2024-2033 年
    • 熱滅菌器
    • 巴氏殺菌器
    • 輻射滅菌器
    • 消毒設備
  • 市場吸引力分析：依產品分類

第 11 章全球醫院感染控制市場分析：依最終使用者劃分

  • 簡介/主要發現
  • 過去的市場規模分析：依最終用戶劃分：2019-2023 年
  • 當前和未來的市場規模分析和預測：依最終用戶劃分，2024-2033 年
    • 醫院
    • 門診手術中心
    • 醫療機構
    • 診斷實驗室
    • 診所
  • 市場吸引力分析：依最終用戶分類

第 12 章全球醫院感染控制市場分析：依地區

  • 簡介
  • 過去的市場規模與銷售分析：依地區劃分，2019-2023 年
  • 當前和未來的市場規模和數量分析與預測：依地區劃分，2024-2033 年
    • 北美
    • 拉丁美洲
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東/非洲
  • 市場吸引力分析：依地區劃分

第十三章北美醫院感染控制市場分析

第十四章拉丁美洲醫院感染控制市場分析

第十五章歐洲醫院感染控制市場分析

第十六章南亞醫院感染控制市場分析

第十七章東亞醫院感染控制市場分析

第十八章大洋洲醫院感染控制市場分析

第十九章中東和非洲 (MEA) 醫院感染控制市場分析

第20章市場結構分析

  • 市場分析：依公司層級
  • 主要公司市佔率分析
  • 市場現況分析

第21章競爭分析

  • 競爭對手儀表板
  • 競爭基準
  • 衝突詳情
    • Olympus Corporation
    • Medivators Inc.（Cantel Medical Corp.）
    • Getinge Group
    • STERIS Plc.
    • Belimed AG（Metall Zug）
    • Steelco SPA
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd
    • Merck &Co.
    • Advanced Sterilization Products Services Inc.（Johnson &Johnson）
    • Abbott Laboratories
    • Bayer AG
    • Alere Inc.
    • The 3M Company
    • Cepheid Inc.
    • UVision360 Inc.

第 22 章先決條件與使用的縮寫

第23章研究方法

簡介目錄
Product Code: PMRREP2814

Persistence Market Research has recently released a comprehensive report on the worldwide market for hospital acquired infection control. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Hospital Acquired Infection Control Market Size (2024E): USD 7.13 Billion
  • Projected Market Value (2033F): USD 10.1 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 3.9%

Hospital Acquired Infection Control Market - Report Scope:

Hospital acquired infections (HAIs) are infections that patients acquire while receiving treatment for medical or surgical conditions in healthcare settings. The market for HAI control includes products and services designed to prevent, diagnose, and treat infections such as urinary tract infections, surgical site infections, pneumonia, and bloodstream infections. Key products in this market include sterilization equipment, disinfectants, surveillance systems, and diagnostic devices. The HAI control market caters to hospitals, clinics, long-term care facilities, and diagnostic laboratories.

Market Growth Drivers:

The global hospital acquired infection control market is propelled by several key factors, including the rising prevalence of HAIs, increasing healthcare expenditures, and stringent regulations aimed at improving patient safety. Advances in sterilization and disinfection technologies, along with the development of innovative diagnostic tools, enhance the efficacy of infection control measures. Additionally, growing awareness and education about infection prevention among healthcare professionals and patients further drive market growth.

Market Restraints:

Despite promising growth prospects, the HAI control market faces challenges related to the high costs of advanced infection control products and equipment, regulatory compliance, and the need for continuous training of healthcare staff. The stringent regulations governing the manufacturing and use of infection control products impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for certain infection control procedures poses challenges for market penetration, particularly in emerging economies with constrained healthcare budgets.

Market Opportunities:

The HAI control market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as real-time infection surveillance systems and electronic health records, enhances the effectiveness of infection control programs. Additionally, the increasing adoption of minimally invasive surgical procedures and the expansion of outpatient care settings create new avenues for market players. Strategic partnerships, investment in research and development, and the introduction of cost-effective, user-friendly infection control solutions are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the hospital acquired infection control market globally?
  • Which products and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the HAI control market?
  • Who are the key players contributing to the HAI control market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global HAI control market?

Competitive Intelligence and Business Strategy:

Leading players in the global hospital acquired infection control market, including 3M Company, Johnson & Johnson, and Becton, Dickinson and Company, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced infection control solutions, such as automated sterilization systems, advanced disinfectants, and rapid diagnostic tests, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving infection control landscape.

Key Companies Profiled:

  • Olympus Corporation
  • Medivators Inc. (Cantel Medical Corp.)
  • Getinge Group
  • STERIS Plc.
  • Belimed AG (Metall Zug)
  • Steelco S.P.A
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co.
  • Advanced Sterilization Products Services Inc. (Johnson & Johnson)
  • Abbott Laboratories
  • Bayer AG
  • Alere Inc.
  • The 3M Company
  • Cepheid Inc
  • UVision360 Inc.

Key Segments of the Hospital Acquired Infection Control Market

By Product :

  • Heat Sterilization Equipment
  • Low-Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
  • Disinfection Equipment

By End User :

  • Hospitals
  • Ambulatory Surgical Centres
  • Medical Institutions
  • Diagnostic Laboratories
  • Clinics

By Region :

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Key Marketing & Promotion Strategies, By Manufacturers
  • 4.3. Regulatory Landscape
  • 4.4. Reimbursement Scenario.
  • 4.5. Quality Monitoring Programs
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis.

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Industry Outlook
    • 5.1.3. Hospital Acquired Infection Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Focus on Personal Hygiene
    • 5.2.2. Increasing Prevalence of Infectious Diseases
    • 5.2.3. New Product Launch Activities
    • 5.2.4. Technological Advancements
    • 5.2.5. Increasing Minimally Invasive Procedures
    • 5.2.6. Susceptible Patients and Surgical Procedures
    • 5.2.7. Co-Existing Infections
    • 5.2.8. Increased Funding and Support from the Government
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2024 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Product
    • 6.2.2. By End User
    • 6.2.3. By Region

7. Global Hospital Acquired Infection Control Market Demand (in Volume) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market (Volume) Analysis, 2019-2023
  • 7.2. Current and Future Market (Volume) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Hospital Acquired Infection Control Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis, By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Hospital Acquired Infection Control Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2033
    • 10.3.1. Heat Sterilization Equipment
      • 10.3.1.1. Moist Heat Sterilization Equipment
      • 10.3.1.2. Dry Heat Sterilization Equipment
    • 10.3.2. Low Temperature Sterilization Equipment
    • 10.3.3. Radiation Sterilization Equipment
    • 10.3.4. Disinfection Equipment
      • 10.3.4.1. Disinfector
        • 10.3.4.1.1. Washer Disinfector
        • 10.3.4.1.2. Flusher Disinfector
      • 10.3.4.2. Endoscopic Reprocessor Systems
        • 10.3.4.2.1. Single Basin Endoscopic Reprocessor Systems
        • 10.3.4.2.2. Dual Basin Endoscopic Reprocessor Systems
      • 10.3.4.3. Disinfectants
  • 10.4. Market Attractiveness Analysis, By Product

11. Global Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2033
    • 11.3.1. Hospitals
    • 11.3.2. Ambulatory Surgical Centers
    • 11.3.3. Medical Institutions
    • 11.3.4. Diagnostic Laboratories
    • 11.3.5. Clinics
  • 11.4. Market Attractiveness Analysis, By End User

12. Global Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. South Asia
    • 12.3.5. East Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa
  • 12.4. Market Attractiveness Analysis, By Region

13. North America Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By End User
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Market Trends
  • 13.8. Country-Level Analysis & Forecast
    • 13.8.1. U.S. Hospital Acquired Infection Control Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By End User
    • 13.8.2. Canada Hospital Acquired Infection Control Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By End User

14. Latin America Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Product
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By End User
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Market Trends
  • 14.8. Country-Level Analysis & Forecast
    • 14.8.1. Mexico Hospital Acquired Infection Control Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By End User
    • 14.8.2. Brazil Surgical Imaging Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By End User
    • 14.8.3. Argentina Hospital Acquired Infection Control Market
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By End User

15. Europe Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. U.K.
      • 15.3.1.2. Germany
      • 15.3.1.3. Italy
      • 15.3.1.4. France
      • 15.3.1.5. Spain
      • 15.3.1.6. Russia
      • 15.3.1.7. BENELUX
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By End User
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Market Trends
  • 15.8. Country-Level Analysis & Forecast
    • 15.8.1. U.K. Hospital Acquired Infection Control Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By End User
    • 15.8.2. Germany Hospital Acquired Infection Control Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By End User
    • 15.8.3. Italy Hospital Acquired Infection Control Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By End User
    • 15.8.4. France Hospital Acquired Infection Control Market
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By End User
    • 15.8.5. Spain Hospital Acquired Infection Control Market
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By End User
    • 15.8.6. Russia Hospital Acquired Infection Control Market
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By End User
    • 15.8.7. BENULUX Hospital Acquired Infection Control Market
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By End User

16. South Asia Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By End User
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Market Trends
  • 16.8. Country-Level Analysis & Forecast
    • 16.8.1. India Hospital Acquired Infection Control Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By End User
    • 16.8.2. Indonesia Hospital Acquired Infection Control Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By End User
    • 16.8.3. Malaysia Hospital Acquired Infection Control Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By End User
    • 16.8.4. Thailand Hospital Acquired Infection Control Market
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By End User

17. East Asia Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Market Trends
  • 17.8. Country-Level Analysis & Forecast
    • 17.8.1. China Hospital Acquired Infection Control Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By End User
    • 17.8.2. Japan Hospital Acquired Infection Control Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By End User
    • 17.8.3. South Korea Hospital Acquired Infection Control Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By End User

18. Oceania Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By End User
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Market Trends
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Hospital Acquired Infection Control Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By End User
    • 18.8.2. New Zealand Hospital Acquired Infection Control Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By End User

19. Middle East and Africa (MEA) Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkey
      • 19.3.1.3. South Africa
      • 19.3.1.4. North Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By End User
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Market Trends
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Hospital Acquired Infection Control Market
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By End User
    • 19.8.2. Turkey Hospital Acquired Infection Control Market
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By End User
    • 19.8.3. South Africa Hospital Acquired Infection Control Market
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Product
        • 19.8.3.2.2. By End User
    • 19.8.4. North Africa Hospital Acquired Infection Control Market
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Product
        • 19.8.4.2.2. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis
    • 20.3.1. Regional footprint of Players
    • 20.3.2. Product foot print by Players
    • 20.3.3. Channel Foot Print by Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Olympus Corporation
      • 21.3.1.1. Company Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Sales Footprint
      • 21.3.1.4. Key Financials
      • 21.3.1.5. SWOT Analysis
      • 21.3.1.6. Key Developments
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. Medivators Inc. (Cantel Medical Corp.)
      • 21.3.2.1. Company Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Sales Footprint
      • 21.3.2.4. Key Financials
      • 21.3.2.5. SWOT Analysis
      • 21.3.2.6. Key Developments
      • 21.3.2.7. Strategy Overview
        • 21.3.2.7.1. Marketing Strategy
        • 21.3.2.7.2. Product Strategy
        • 21.3.2.7.3. Channel Strategy
    • 21.3.3. Getinge Group
      • 21.3.3.1. Company Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Sales Footprint
      • 21.3.3.4. Key Financials
      • 21.3.3.5. SWOT Analysis
      • 21.3.3.6. Key Developments
      • 21.3.3.7. Strategy Overview
        • 21.3.3.7.1. Marketing Strategy
        • 21.3.3.7.2. Product Strategy
        • 21.3.3.7.3. Channel Strategy
    • 21.3.4. STERIS Plc.
      • 21.3.4.1. Company Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Sales Footprint
      • 21.3.4.4. Key Financials
      • 21.3.4.5. SWOT Analysis
      • 21.3.4.6. Key Developments
      • 21.3.4.7. Strategy Overview
        • 21.3.4.7.1. Marketing Strategy
        • 21.3.4.7.2. Product Strategy
        • 21.3.4.7.3. Channel Strategy
    • 21.3.5. Belimed AG (Metall Zug)
      • 21.3.5.1. Company Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Sales Footprint
      • 21.3.5.4. Key Financials
      • 21.3.5.5. SWOT Analysis
      • 21.3.5.6. Key Developments
      • 21.3.5.7. Strategy Overview
        • 21.3.5.7.1. Marketing Strategy
        • 21.3.5.7.2. Product Strategy
        • 21.3.5.7.3. Channel Strategy
    • 21.3.6. Steelco S.P.A
      • 21.3.6.1. Company Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Sales Footprint
      • 21.3.6.4. Key Financials
      • 21.3.6.5. SWOT Analysis
      • 21.3.6.6. Key Developments
      • 21.3.6.7. Strategy Overview
        • 21.3.6.7.1. Marketing Strategy
        • 21.3.6.7.2. Product Strategy
        • 21.3.6.7.3. Channel Strategy
    • 21.3.7. Pfizer Inc.
      • 21.3.7.1. Company Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Sales Footprint
      • 21.3.7.4. Key Financials
      • 21.3.7.5. SWOT Analysis
      • 21.3.7.6. Key Developments
      • 21.3.7.7. Strategy Overview
        • 21.3.7.7.1. Marketing Strategy
        • 21.3.7.7.2. Product Strategy
        • 21.3.7.7.3. Channel Strategy
    • 21.3.8. F. Hoffmann-La Roche Ltd
      • 21.3.8.1. Company Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Sales Footprint
      • 21.3.8.4. Key Financials
      • 21.3.8.5. SWOT Analysis
      • 21.3.8.6. Key Developments
      • 21.3.8.7. Strategy Overview
        • 21.3.8.7.1. Marketing Strategy
        • 21.3.8.7.2. Product Strategy
        • 21.3.8.7.3. Channel Strategy
    • 21.3.9. Merck & Co.
      • 21.3.9.1. Company Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Sales Footprint
      • 21.3.9.4. Key Financials
      • 21.3.9.5. SWOT Analysis
      • 21.3.9.6. Key Developments
      • 21.3.9.7. Strategy Overview
        • 21.3.9.7.1. Marketing Strategy
        • 21.3.9.7.2. Product Strategy
        • 21.3.9.7.3. Channel Strategy
    • 21.3.10. Advanced Sterilization Products Services Inc. (Johnson & Johnson)
      • 21.3.10.1. Company Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Sales Footprint
      • 21.3.10.4. Key Financials
      • 21.3.10.5. SWOT Analysis
      • 21.3.10.6. Key Developments
      • 21.3.10.7. Strategy Overview
        • 21.3.10.7.1. Marketing Strategy
        • 21.3.10.7.2. Product Strategy
        • 21.3.10.7.3. Channel Strategy
    • 21.3.11. Abbott Laboratories
      • 21.3.11.1. Company Overview
      • 21.3.11.2. Product Portfolio
      • 21.3.11.3. Sales Footprint
      • 21.3.11.4. Key Financials
      • 21.3.11.5. SWOT Analysis
      • 21.3.11.6. Key Developments
      • 21.3.11.7. Strategy Overview
        • 21.3.11.7.1. Marketing Strategy
        • 21.3.11.7.2. Product Strategy
        • 21.3.11.7.3. Channel Strategy
    • 21.3.12. Bayer AG
      • 21.3.12.1. Company Overview
      • 21.3.12.2. Product Portfolio
      • 21.3.12.3. Sales Footprint
      • 21.3.12.4. Key Financials
      • 21.3.12.5. SWOT Analysis
      • 21.3.12.6. Key Developments
      • 21.3.12.7. Strategy Overview
        • 21.3.12.7.1. Marketing Strategy
        • 21.3.12.7.2. Product Strategy
        • 21.3.12.7.3. Channel Strategy
    • 21.3.13. Alere Inc.
      • 21.3.13.1. Company Overview
      • 21.3.13.2. Product Portfolio
      • 21.3.13.3. Sales Footprint
      • 21.3.13.4. Key Financials
      • 21.3.13.5. SWOT Analysis
      • 21.3.13.6. Key Developments
      • 21.3.13.7. Strategy Overview
        • 21.3.13.7.1. Marketing Strategy
        • 21.3.13.7.2. Product Strategy
        • 21.3.13.7.3. Channel Strategy
    • 21.3.14. The 3M Company
      • 21.3.14.1. Company Overview
      • 21.3.14.2. Product Portfolio
      • 21.3.14.3. Sales Footprint
      • 21.3.14.4. Key Financials
      • 21.3.14.5. SWOT Analysis
      • 21.3.14.6. Key Developments
      • 21.3.14.7. Strategy Overview
        • 21.3.14.7.1. Marketing Strategy
        • 21.3.14.7.2. Product Strategy
        • 21.3.14.7.3. Channel Strategy
    • 21.3.15. Cepheid Inc.
      • 21.3.15.1. Company Overview
      • 21.3.15.2. Product Portfolio
      • 21.3.15.3. Sales Footprint
      • 21.3.15.4. Key Financials
      • 21.3.15.5. SWOT Analysis
      • 21.3.15.6. Key Developments
      • 21.3.15.7. Strategy Overview
        • 21.3.15.7.1. Marketing Strategy
        • 21.3.15.7.2. Product Strategy
        • 21.3.15.7.3. Channel Strategy
    • 21.3.16. UVision360 Inc.
      • 21.3.16.1. Company Overview
      • 21.3.16.2. Product Portfolio
      • 21.3.16.3. Sales Footprint
      • 21.3.16.4. Key Financials
      • 21.3.16.5. SWOT Analysis
      • 21.3.16.6. Key Developments
      • 21.3.16.7. Strategy Overview
        • 21.3.16.7.1. Marketing Strategy
        • 21.3.16.7.2. Product Strategy
        • 21.3.16.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology